核心观点 - 处方药成本上升成为医疗保健领域的主要关注点 药房福利管理公司(PBMs)因管理处方药福利的角色受到更严格审查 [1] - CVS Health旗下Caremark业务获得加州公共雇员退休系统(CalPERS)为期五年的药房福利管理合同 取代OptumRx [1] - CVS Caremark被选中因其提供更实惠药品福利的能力 以及对问责制、透明度和开创性财务担保的承诺 [3] - CVS Health在商业模板处方集中优先选择Wegovy而非Zepbound 旨在促进竞争降低药品成本 客户每年可在抗肥胖药物领域节省10-15% [4] CVS Health与CalPERS合同细节 - 自2026年1月1日起 Caremark将为约587,000名成员提供门诊处方药福利 占CalPERS 150万受益人的约40% [2] - CVS将与CalPERS密切合作 制定管理处方集变更的方案 可能影响共付额或需要转换同等有效的替代药物 [2] - CVS投入2.5亿美元风险资金 若未能达到控制药房福利成本目标和改善高血压及糖尿病护理的临床质量结果 [3] - 该合同将CVS Caremark置于CalPERS努力创建可成为"全国购买者蓝图"的模型前沿 [3] PBM行业动态 - 全球PBM市场正在扩张 CVS Caremark、OptumRx和Express Scripts主导市场 [5] - Elevance Health通过CarelonRx部门提供药房服务 2025年第二季度Carelon运营收益同比增长33% 主要由于药房会员增加和近期收购贡献 [5] - Humana在保险部门下运营PBM业务 近期与医疗软件公司Epic合作 成为首家将健康计划信息直接整合到MyChart账户的健康保险公司 [6] CVS财务表现与估值 - 过去一年 CVS Health股价上涨6.3% 而行业下跌17.7% [7] - CVS股票远期一年市盈率为9.60 低于行业平均14.00 价值评分为A [9] - 分析师对公司2025年和2026年盈利预期呈上升趋势 [10] - 当前季度(2025年6月)每股收益预期为1.47美元 2026年全年预期为7.00美元 [11] - CVS股票目前获得Zacks Rank 1(强力买入)评级 [11]

According to a SEC filing dated July 10, Ferguson Wellman Capital Management sold 155,436 shares of UnitedHealth Group(UNH -1.34%) during the quarter ending June 30, 2025, with transactions totaling $59.76 million. The fund's remaining position stood at 33,063 shares worth $10.31 million as of June 30, 2025. What else to know What happened Ferguson Wellman's sale reduced UnitedHealth Group to 0.18% of its $5.68 billion 13F AUM. Top five holdings as of June 30, 2025: Other things to know about UnitedHealth G ...

CVS Health Corporation (CVS) is scheduled to report first-quarter 2025 results on May 1, before the opening bell. 3 Factors to Focus on Ahead of CVS' Q1 Earnings A Turnaround at Aetna Expected: Aetna's underperformance in 2024 was concerning. However, CVS expected benefit redesigns and improved rate negotiations to lead to margin recovery starting from 2025. While utilization trends remained elevated in the fourth quarter of 2024, data showed moderation in inpatient costs, a positive sign for medical cost c ...